Physician

Ahmad Zarzour, M.D.

According to 2025 Medicare claims, Ahmad Zarzour, M.D. (NPI: 1992149041) practices hematology/oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is NORTHWESTERN MEDICAL FACULTY FOUNDATION (NPI: 1346235314; TIN: 363097297) and primary practice location at 60462-4600. Zarzour is affiliated with the Mercy Health Select, LLC (ACO ID: A1215) and CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under both the MSSP and REACH models.

Zarzour's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 479 traditional Medicare patients, billed 51,976 HCPCS/CPT codes, and received $1,033,803 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,068 prescription claims across 182 beneficiaries totaling $2,378,928 in drug costs, led by Brukinsa (Zanubrutinib). 2017 DME data shows 58 claims. Open Payments data shows 52 records totaling $71,900. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $52,352 to $1,033,803. Similarly, Part D prescription costs have moved sharply higher in recent years, from $19,964 to $2,378,928. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	247	658	$52,352
2017	531	1,573	$129,612
2018	229	525	$45,673
2019	N/R	N/R	N/R
2020	111	262	$27,007
2021	445	44,420	$683,445
2022	502	67,062	$1,252,118
2023	461	54,785	$1,220,464
2024	479	51,976	$1,033,803

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	62	334	$19,964
2016	53	139	$9,077
2017	33	62	$9,480
2018	12	19	$1,816
2019	17	39	$51,070
2020	34	78	$137,411
2021	76	267	$542,715
2022	128	409	$712,767
2023	149	723	$1,457,963
2024	182	1,068	$2,378,928

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	58	58	$38,644
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	46	113	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	178	525	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	206	263	$57
96367	Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less	38	107	$20
96372	Injection of drug or substance under skin or into muscle	37	71	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Brukinsa	Zanubrutinib	56	1,680	$817,182
Calquence	Acalabrutinib Maleate	20	600	$287,995
Lenalidomide	Lenalidomide	20	560	$283,796
Revlimid	Lenalidomide	14	385	$266,386
Ibrance	Palbociclib	14	392	$210,889

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	49	$14,999	Daiichi Sankyo Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$56,901	Celgene Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmad Zarzour, M.D.?

Tedicare shows public-source Medicare data for Ahmad Zarzour, M.D. (NPI 1992149041), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad Zarzour, M.D. have ACO affiliation data?

Ahmad Zarzour, M.D. is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215) and CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Ahmad Zarzour, M.D.?

Ahmad Zarzour, M.D. is linked to NORTHWESTERN MEDICAL FACULTY FOUNDATION (billing NPI 1346235314) in the available physician profile data.

Does Ahmad Zarzour, M.D. have Open Payments data?

Ahmad Zarzour, M.D. has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.